CA2615947A1 - Protein profile for osteoarthritis - Google Patents

Protein profile for osteoarthritis Download PDF

Info

Publication number
CA2615947A1
CA2615947A1 CA002615947A CA2615947A CA2615947A1 CA 2615947 A1 CA2615947 A1 CA 2615947A1 CA 002615947 A CA002615947 A CA 002615947A CA 2615947 A CA2615947 A CA 2615947A CA 2615947 A1 CA2615947 A1 CA 2615947A1
Authority
CA
Canada
Prior art keywords
expression
osteoarthritis
subject
group
difference
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002615947A
Other languages
English (en)
French (fr)
Inventor
Peter J. Millett
David A. Sarracino
Bryan Krastins
Reuben Gobezie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2615947A1 publication Critical patent/CA2615947A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002615947A 2005-06-17 2006-06-16 Protein profile for osteoarthritis Abandoned CA2615947A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69204005P 2005-06-17 2005-06-17
US60/692,040 2005-06-17
PCT/US2006/023619 WO2006138646A2 (en) 2005-06-17 2006-06-16 Protein profile for osteoarthritis

Publications (1)

Publication Number Publication Date
CA2615947A1 true CA2615947A1 (en) 2006-12-28

Family

ID=37387398

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002615947A Abandoned CA2615947A1 (en) 2005-06-17 2006-06-16 Protein profile for osteoarthritis

Country Status (6)

Country Link
US (1) US20100292154A1 (https=)
EP (1) EP1894016A2 (https=)
JP (2) JP2008547006A (https=)
AU (1) AU2006261641B2 (https=)
CA (1) CA2615947A1 (https=)
WO (1) WO2006138646A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8224579B2 (en) * 2005-06-17 2012-07-17 The Brigham And Women's Hospital, Inc. Method of diagnosing osteoarthritis
AU2008247705B2 (en) * 2007-05-01 2012-02-09 Hill's Pet Nutrition, Inc. Methods and compositions for diagnosing osteoarthritis in a feline
EP2131199A1 (en) * 2008-06-03 2009-12-09 Université de Liège Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
US8771968B2 (en) 2008-06-03 2014-07-08 Universitè de Liège Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
JP2011117813A (ja) * 2009-12-02 2011-06-16 Hokuriku Univ 変形性関節症のマーカーおよびそれを用いた診断
CA2792163A1 (en) * 2010-03-05 2011-09-09 The Curators Of The University Of Missouri Biomarkers of osteoarthritis
AU2012253691B2 (en) 2011-05-10 2016-05-19 Société des Produits Nestlé S.A. Methods for diagnosing degenerative joint disease
AU2012367247B2 (en) * 2012-01-24 2018-04-05 Cd Diagnostics, Inc. System for detecting infection in synovial fluid
JP6768922B2 (ja) * 2016-04-15 2020-10-14 イーエスエム テクノロジーズ エルエルシーＥＳＭ Ｔｅｃｈｎｏｌｏｇｉｅｓ， ＬＬＣ 関節部治療薬を評価するための方法
JP7421744B2 (ja) * 2019-08-28 2024-01-25 学校法人順天堂 変形性関節症の診断

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026651A (en) * 1985-04-25 1991-06-25 Board Of Regents, The University Of Texas System Methods and compositions for the production of human transferrin
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
JP3265577B2 (ja) * 1992-10-13 2002-03-11 デューク・ユニバーシティ アポリポ蛋白ｅの４型イソ型の測定法
JP2004536575A (ja) * 2001-02-28 2004-12-09 コンドロジーン・インコーポレイテッド 変形性関節症に関連する組成物および方法
DE10127572A1 (de) * 2001-05-30 2002-12-05 Pathoarray Gmbh Werkzeuge zur Diagnostik, molekularen Definition und Therapieentwicklung chronischer entzündlicher Gelenkerkrankungen
US20030224386A1 (en) * 2001-12-19 2003-12-04 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of rheumatoid arthritis
US20030224989A1 (en) * 2002-02-12 2003-12-04 Kerry Quinn Compositions and methods for treatment of osteoarthritis
JP4538637B2 (ja) * 2003-03-31 2010-09-08 国立大学法人九州大学 アポリポタンパクｅ遺伝子多型検出方法、アポリポタンパクｅ遺伝子多型のゲノタイプ判定方法及び試薬
EP2128270B1 (en) * 2003-08-08 2012-10-03 Genenews Inc. Osteoarthritis biomarkers and uses thereof
WO2006023412A2 (en) * 2004-08-18 2006-03-02 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Biomarkers for osteoarthritis

Also Published As

Publication number Publication date
JP2008547006A (ja) 2008-12-25
AU2006261641A1 (en) 2006-12-28
EP1894016A2 (en) 2008-03-05
JP2012073274A (ja) 2012-04-12
US20100292154A1 (en) 2010-11-18
AU2006261641B2 (en) 2011-09-29
WO2006138646A3 (en) 2007-06-07
WO2006138646A2 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
WO2010085606A1 (en) Protein biomarkers and therapeutic targets for osteoarthritis
JP2012073274A (ja) 変形性関節症のタンパク質プロフィール
US20180106817A1 (en) Protein biomarkers and therapeutic targets for renal disorders
Mobasheri Osteoarthritis year 2012 in review: biomarkers
Ottervald et al. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers
WO2008074029A2 (en) Protein profile for osteoarthritis
US9733257B2 (en) Biomarkers of osteoarthritis
US20250172556A1 (en) Biomarkers and methods for assessing response to inflammatory disease therapy withdrawal
WO2008064336A9 (en) Autoimmune disease biomarkers
JP7535270B2 (ja) 子宮内膜症の診断方法、病態モニタリング方法及びキット
WO2007133586A2 (en) Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets
JP2020500293A (ja) 大腸癌及び進行性腺腫を検知するためのタンパク質バイオマーカーパネル
WO2011014349A1 (en) Serum markers predicting clinical response to anti-tnfalpha antibodies in patients with psoriatic arthritis
CA3207751A1 (en) Biomarkers and methods for assessing psoriatic arthritis disease activity
KR101992060B1 (ko) 알츠하이머치매 진단 체액 바이오마커 후보 단백4종
WO2008131261A2 (en) Peptide biomarkers of cardiovascular disease
US20050266467A1 (en) Biomarkers for multiple sclerosis and methods of use thereof
US20180292384A1 (en) Urine metabolite profiles identify kidney allograft status
US8372594B2 (en) Secreted phospholipase A2 biomarkers for arthritis
KR102039816B1 (ko) 신장이식 후 이식 장기의 섬유증 진단 또는 예측용 바이오마커
JP2011237402A (ja) ガレクチン−３結合蛋白質による脳梗塞の検査方法
WO2024059913A1 (en) Methods and kits for assessing medical risk
WO2025096715A1 (en) Compositions and methods for the detection and treatment of acute pancreatitis
WO2012067150A1 (ja) Interleukin-6 receptor subunit beta蛋白質による脳梗塞の検査方法
JP2012107933A (ja) Ｈｅｍｏｐｅｘｉｎ蛋白質による脳梗塞の検査方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20140617